COX-2-selective antiinflammatory, antiphlogistic and analgesic series claimed by Theramex July 2, 2001
Novel class of molecules --the SGRMs-- with potential therapeutic benefits over glucocorticoids June 22, 2001
Valdecoxib compares favorably to conventional NSAIDs in terms of both efficacy and safety June 22, 2001
PEG sTNF-RI produces significant improvement in signs, symptoms and HRQOL in RA patients June 19, 2001
RSS